RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Est. Return
12.81%
1 Year Est. Return
+12.81%
AUM
$870M
AUM Growth
-$103M
(-11%)
Holding
104
Top Buys
| 1 | +$23M | |
| 2 | +$19.8M | |
| 3 | +$11.2M | |
| 4 |
Molina Healthcare
MOH
|
+$11.2M |
| 5 |
DexCom
DXCM
|
+$10.6M |
Top Sells
| 1 | +$21.9M | |
| 2 | +$21.4M | |
| 3 | +$16.5M | |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$14.7M |
| 5 |
Boston Scientific
BSX
|
+$14.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
IQVIA
IQV
$36.9B
| $3.88M | 0.45% |
22,000
-7,000
|
|
||
52
Janux Therapeutics
JANX
$1.76B
| $3.82M | 0.44% |
141,627
-28,373
|
|
||
53
Encompass Health
EHC
$12.7B
| $3.79M | 0.44% |
37,400
-18,600
|
|
||
54
Akero Therapeutics
AKRO
$4.33B
| $3.74M | 0.43% |
+92,500
|
|
||
55
Nuvalent
NUVL
$7.22B
| $3.72M | 0.43% |
52,500
-20,000
|
|
||
56
Mirum Pharmaceuticals
MIRM
$3.54B
| $3.32M | 0.38% |
73,755
|
|
||
57
BioNTech
BNTX
$25.5B
| $3.26M | 0.37% |
35,750
-17,000
|
|
||
58
Krystal Biotech
KRYS
$5.45B
| $3.2M | 0.37% |
17,750
-6,000
|
|
||
59
Merus
MRUS
$7.19B
| $3.14M | 0.36% |
74,500
|
|
||
60
Ultragenyx Pharmaceutical
RARE
$3.41B
| $2.97M | 0.34% |
+82,000
|
|
||
61
Nurix Therapeutics
NRIX
$1.22B
| $2.96M | 0.34% |
249,336
-40,664
|
|
||
62
Merck
MRK
$218B
| $2.96M | 0.34% |
33,000
-244,500
|
|
||
63
Arcellx
ACLX
$4.87B
| $2.85M | 0.33% |
43,500
|
|
||
64
Inspire Medical Systems
INSP
$2.24B
| $2.55M | 0.29% |
16,000
-134,041
|
|
||
65
Ionis Pharmaceuticals
IONS
$11.7B
| $2.44M | 0.28% |
81,000
-131,500
|
|
||
66
Viking Therapeutics
VKTX
$3.98B
| $2.42M | 0.28% |
100,000
+10,000
|
|
||
67
Dianthus Therapeutics
DNTH
$1.36B
| $2.3M | 0.26% |
126,627
+12,627
|
|
||
68
Privia Health
PRVA
$3.19B
| $2.2M | 0.25% |
98,189
-23,000
|
|
||
69
Iovance Biotherapeutics
IOVA
$803M
| $2.16M | 0.25% |
647,827
-587,621
|
|
||
70
Xencor
XNCR
$1.02B
| $2.08M | 0.24% |
195,750
|
|
||
71
Bruker
BRKR
$5.86B
| $1.77M | 0.2% |
42,315
+6,000
|
|
||
72
MoonLake Immunotherapeutics
MLTX
$636M
| $1.76M | 0.2% |
+45,000
|
|
||
73
Esperion Therapeutics
ESPR
$718M
| $1.54M | 0.18% |
1,066,495
-848,505
|
|
||
74
INmune Bio
INMB
$48.1M
| $1.39M | 0.16% |
178,284
|
|
||
75
Denali Therapeutics
DNLI
$2.48B
| $1.36M | 0.16% |
+100,000
|
|